Atlas Trials

Pharmacokinetic Interactions Between Hydronidone and Entecavir Capsules in Healthy Chinese Subjects

Clinical trial NCT04124081 · COMPLETED

Trial details

NCT number
NCT04124081
Sponsor
Beijing Continent Pharmaceutical Co, Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hydronidone
Start date
2019-05-15
Primary completion
2019-06-15
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.